• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

    7/23/25 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    • Record revenue of $1.7 billion, up 10% from Q2 2024
    • Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024

    CHICAGO, July 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the second quarter of 2025.

    The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2025. Net income was $1.0 billion and diluted earnings per common share were $2.81. On an adjusted basis, net income was $1.1 billion and diluted earnings per common share were $2.96. Financial results presented on an adjusted basis for the second quarter of 2025 and 2024 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1

    "Demand for CME Group benchmark futures and options reached an all-time high in Q2 as clients around the globe turned to our markets to manage their business risks across asset classes," said Terry Duffy, CME Group Chairman and Chief Executive Officer. "During the quarter, our average daily volume rose 16% to a record 30.2 million contracts, driving double-digit growth and setting new records for revenue, adjusted operating income, adjusted net income and adjusted earnings per share. Notably, the number of new retail traders at CME Group increased 57% year over year, contributing to record Micros ADV of 4.1 million contracts in Q2 and demonstrating the appeal of our products to a broader base of users."

    1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

    Clearing and transaction fees revenue for second-quarter 2025 totaled $1.4 billion. The total average rate per contract was $0.690. Market data revenue totaled $198 million for second-quarter 2025.

    As of June 30, 2025 the company had $2.2 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the first six months of the year of approximately $3.0 billion. The company has returned $29.1 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

    CME Group will hold a Q&A conference call to discuss second-quarter 2025 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.

    As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

    CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

    Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs relating to CME Group's transition to the Google Cloud and minimize duplicative costs during the transition between maintaining the on-premise environment and the Google Cloud environment; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes and the related uncertainty thereof, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors (ISVs), Futures Commission Merchants (FCMs), introducing brokers, broker-dealers around the world, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new or existing geopolitical  conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements without failure or degradation of the performance of our trading and clearing systems and meeting our regulatory reporting obligations; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services, our primary business and distribution partners' actions and our partnership with Google Cloud, including our ability to manage the successful implementation of our agreements with Google and our data center partners; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings.  For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission ("SEC") on February 27, 2025, under the caption "Risk Factors".

    CME Group Inc. and Subsidiaries

    Consolidated Balance Sheets

    (in millions)







    June 30, 2025



    December 31, 2024

    ASSETS









    Current Assets:









    Cash and cash equivalents



    $                 1,981.3



    $                  2,892.4

    Marketable securities



    117.6



    113.2

    Accounts receivable, net of allowance



    667.6



    573.1

    Other current assets (includes $6.5 and $6.3 in restricted cash)



    525.6



    559.4

    Performance bonds and guaranty fund contributions



    142,158.0



    98,895.4

    Total current assets



    145,450.1



    103,033.5

    Property, net of accumulated depreciation and amortization



    362.9



    386.2

    Intangible assets—trading products



    17,175.3



    17,175.3

    Intangible assets—other, net



    2,728.5



    2,821.6

    Goodwill



    10,523.9



    10,486.9

    Other assets



    3,666.3



    3,543.5

    Total Assets



    $             179,907.0



    $              137,447.0

    LIABILITIES AND EQUITY









    Current Liabilities:









    Accounts payable



    $                      92.3



    $                       79.9

    Short-term debt



    —



    749.8

    Other current liabilities



    544.5



    2,588.8

    Performance bonds and guaranty fund contributions



    142,158.0



    98,895.4

    Total current liabilities



    142,794.8



    102,313.9

    Long-term debt



    3,420.4



    2,678.2

    Deferred income tax liabilities, net



    5,232.6



    5,246.8

    Other liabilities



    720.2



    721.2

    Total Liabilities



    152,168.0



    110,960.1

    Total CME Group Shareholders' Equity



    27,739.0



    26,486.9

    Total Liabilities and Equity



    $             179,907.0



    $              137,447.0

     

    CME Group Inc. and Subsidiaries

    Consolidated Statements of Income

    (dollars in millions, except per share amounts; shares in thousands)







    Quarter Ended

    June 30,



    Six Months Ended

    June 30,





    2025



    2024



    2025



    2024

    Revenues

















    Clearing and transaction fees



    $   1,388.0



    $   1,249.9



    $  2,725.3



    $  2,458.8

    Market data and information services



    198.1



    175.0



    392.6



    350.4

    Other



    105.9



    107.6



    216.4



    211.2

    Total Revenues



    1,692.0



    1,532.5



    3,334.3



    3,020.4

    Expenses

















    Compensation and benefits



    221.6



    204.7



    428.3



    410.7

    Technology



    70.9



    64.1



    136.6



    123.5

    Professional fees and outside services



    37.4



    34.7



    65.9



    67.8

    Amortization of purchased intangibles



    56.1



    55.5



    111.3



    110.7

    Depreciation and amortization



    27.3



    28.7



    54.6



    58.8

    Licensing and other fee agreements



    96.2



    85.9



    192.8



    173.8

    Other



    53.2



    58.3



    107.5



    114.9

    Total Expenses



    562.7



    531.9



    1,097.0



    1,060.2

    Operating Income



    1,129.3



    1,000.6



    2,237.3



    1,960.2

    Non-Operating Income (Expense)

















    Investment income



    1,518.4



    1,044.5



    2,411.1



    2,115.8

    Interest and other borrowing costs



    (44.0)



    (40.1)



    (85.7)



    (80.0)

    Equity in net earnings of unconsolidated subsidiaries



    99.0



    86.4



    187.2



    173.6

    Other non-operating income (expense)



    (1,372.4)



    (936.9)



    (2,174.8)



    (1,901.7)

    Total Non-Operating Income (Expense)



    201.0



    153.9



    337.8



    307.7

    Income before Income Taxes



    1,330.3



    1,154.5



    2,575.1



    2,267.9

    Income tax provision



    305.2



    271.3



    593.8



    529.5

    Net Income



    $   1,025.1



    $       883.2



    $  1,981.3



    $  1,738.4

    Net Income Attributable to Common Shareholders of CME Group



    $   1,012.2



    $       872.1



    $  1,956.4



    $  1,716.5



















    Earnings per Share Attributable to Common Shareholders of CME

    Group:

















    Basic



    $         2.81



    $         2.43



    $        5.44



    $        4.78

    Diluted



    2.81



    2.42



    5.43



    4.77

    Weighted Average Number of Common Shares:

















    Basic



    359,658



    359,330



    359,636



    359,294

    Diluted



    360,355



    359,869



    360,297



    359,852

     

    CME Group Inc. and Subsidiaries

    Reconciliation of GAAP to non-GAAP Measures

    (dollars in millions, except per share amounts; shares in thousands)























    Quarter Ended

    June 30,



    Six Months Ended

    June 30,





    2025



    2024



    2025



    2024

    Net Income



    $    1,025.1



    $       883.2



    $  1,981.3



    $  1,738.4

    Restructuring and severance



    1.4



    0.8



    2.5



    3.6

    Amortization of purchased intangibles(1)



    69.4



    68.9



    137.6



    137.6

    Strategic transaction-related costs (credits)



    2.8



    (1.1)



    2.8



    0.8

    Real estate-related costs (credits)



    (8.1)



    (1.0)



    (8.1)



    (1.0)

    Foreign exchange transaction (gains) losses



    3.6



    (0.3)



    5.9



    (2.1)

    Unrealized and realized (gains) losses on investments



    —



    (9.2)



    6.5



    (11.7)

    Unrealized and realized (gains) losses on assets



    0.4



    —



    0.4



    0.8

    Litigation matters or settlements



    7.6



    —



    10.9



    —

    Income tax effect related to above



    (15.5)



    (11.0)



    (31.6)



    (25.0)

    Other income tax items(2)



    (7.3)



    1.9



    (8.9)



    1.9

    Adjusted Net Income



    $    1,079.4



    $       932.2



    $  2,099.3



    $  1,843.3



















    Adjusted Net Income Attributable to Common Shareholders of CME

    Group



    $    1,065.8



    $       920.4



    $  2,072.9



    $  1,820.1



















    Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $         2.81



    $         2.43



    $       5.44



    $       4.78

         Diluted



    2.81



    2.42



    5.43



    4.77



















    Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:









         Basic



    $         2.96



    $         2.56



    $       5.76



    $       5.07

         Diluted



    2.96



    2.56



    5.75



    5.06



















    Weighted Average Number of Common Shares:

















         Basic



    359,658



    359,330



    359,636



    359,294

         Diluted



    360,355



    359,869



    360,297



    359,852

         Preferred shares(3)



    4,584



    4,584



    4,584



    4,584



    1. Includes $10.8 million and $21.3 million of amortization of purchased intangibles (net of tax) at OSTTRA and $2.5 million and $4.9 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC in the second quarter and first six months of 2025. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.

    2. Other income tax items in the second quarter of 2025 includes $7.2 million of benefits resulting from the recognition of a deferred tax asset related to the investment in the OSTTRA joint venture.

    3. Preferred shares have similar rights as common shares without voting rights.

     

    CME Group Inc. and Subsidiaries

    Quarterly Operating Statistics







    2Q 2024



    3Q 2024



    4Q 2024



    1Q 2025



    2Q 2025

    Trading Days



    63



    64



    64



    61



    62

     

    Quarterly Average Daily Volume (ADV)(1)

    CME Group ADV (in thousands)



    Product Line



    2Q 2024



    3Q 2024



    4Q 2024



    1Q 2025



    2Q 2025

    Interest rates



    12,894



    14,881



    13,244



    15,029



    15,472

    Equity indexes



    6,779



    7,407



    6,343



    7,997



    7,661

    Foreign exchange



    1,075



    1,089



    969



    1,149



    1,096

    Energy



    2,447



    2,571



    2,519



    2,903



    3,082

    Agricultural commodities



    1,877



    1,614



    1,755



    1,958



    1,964

    Metals



    868



    728



    673



    732



    943

    Total



    25,941



    28,289



    25,503



    29,768



    30,217

    Venue





















    CME Globex



    24,143



    26,199



    23,684



    27,732



    28,097

    Open outcry



    825



    1,096



    848



    881



    993

    Privately negotiated



    974



    994



    971



    1,154



    1,127

    Total



    25,941



    28,289



    25,503



    29,768



    30,217

     

    Quarterly Average Rate Per Contract (RPC)(1)

    CME Group RPC



    Product Line



    2Q 2024



    3Q 2024



    4Q 2024



    1Q 2025



    2Q 2025

    Interest rates



    $          0.484



    $          0.468



    $          0.485



    $          0.476



    $          0.481

    Equity indexes



    0.628



    0.616



    0.658



    0.624



    0.635

    Foreign exchange



    0.754



    0.744



    0.778



    0.762



    0.772

    Energy



    1.297



    1.246



    1.237



    1.222



    1.138

    Agricultural commodities



    1.366



    1.346



    1.359



    1.376



    1.435

    Metals



    1.511



    1.540



    1.530



    1.588



    1.456

    Average RPC



    $          0.708



    $          0.666



    $          0.701



    $          0.686



    $          0.690



    1. ADV and RPC includes futures and options on futures only.

    CME-G

    Cision View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-all-time-record-revenue-adjusted-operating-income-adjusted-net-income-and-adjusted-earnings-per-share-for-q2-2025-302511347.html

    SOURCE CME Group

    Get the next $CME alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    7/24/2025$305.00Buy → Neutral
    UBS
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CME Group downgraded by UBS with a new price target

      UBS downgraded CME Group from Buy to Neutral and set a new price target of $305.00

      7/24/25 7:57:18 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00

      4/8/25 9:08:11 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group upgraded by Raymond James with a new price target

      Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00

      3/10/25 7:18:35 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Financials

    Live finance-specific insights

    See more
    • CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

      Record revenue of $1.7 billion, up 10% from Q2 2024Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024CHICAGO, July 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the second quarter of 2025. The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2025. Net income was $1.0 billion and diluted earnings per common share were $2.81. On an adjusted basis, net income was $1.1 billion and diluted earnings per common share were $2.96. Financial results presented on an adjusted basis for the second quarter of 2025 and 2024 exclude certain items, which are detailed in the reconc

      7/23/25 7:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. Announces Second-Quarter 2025 Earnings Release, Conference Call

      CHICAGO, June 17, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the second quarter of 2025 before the markets open on Wednesday, July 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions. A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing to

      6/17/25 4:04:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Declares Quarterly Dividend

      CHICAGO, May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultu

      5/8/25 7:30:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/24 5:02:29 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/13/23 2:49:27 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

      SC 13G/A - CME GROUP INC. (0001156375) (Subject)

      2/11/22 3:04:00 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Shepard William R was granted 879 units of Common Stock Class A and bought $72,336 worth of Common Stock Class A (267 units at $270.53), increasing direct ownership by 0.46% to 2,455 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:11:41 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Shepard William R bought $71,995 worth of Common Stock Class A (274 units at $262.62), increasing direct ownership by 0.48% to 2,443 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 7:19:14 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: Director Shepard William R bought $324,198 worth of Common Stock Class A (1,422 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

      4/A - CME GROUP INC. (0001156375) (Issuer)

      3/27/25 6:55:07 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    SEC Filings

    See more
    • CME Group Inc. filed SEC Form 8-K: Other Events

      8-K - CME GROUP INC. (0001156375) (Filer)

      7/25/25 4:19:56 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 10-Q filed by CME Group Inc.

      10-Q - CME GROUP INC. (0001156375) (Filer)

      7/24/25 8:01:19 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - CME GROUP INC. (0001156375) (Filer)

      7/23/25 7:08:45 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

      Record revenue of $1.7 billion, up 10% from Q2 2024Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024CHICAGO, July 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the second quarter of 2025. The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2025. Net income was $1.0 billion and diluted earnings per common share were $2.81. On an adjusted basis, net income was $1.1 billion and diluted earnings per common share were $2.96. Financial results presented on an adjusted basis for the second quarter of 2025 and 2024 exclude certain items, which are detailed in the reconc

      7/23/25 7:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039

      CHICAGO, July 22, 2025 /PRNewswire/ -- CME Group and Nasdaq (NASDAQ:NDAQ) today announced a ten-year extension of CME Group's exclusive license to offer futures and options on futures based on the Nasdaq-100 and other Nasdaq indexes, through 2039. As the world's leading derivatives marketplace, CME Group operates the largest equity index futures complex in the world. Nasdaq is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. "Extending our exclusive licensing agreement with Nasdaq will ensure that global market participants continue to have seamless access to our deeply liquid Nasdaq futures and options on futures, which

      7/22/25 3:00:00 PM ET
      $CME
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year

      Record Europe, Middle East and Africa (EMEA) ADV of 6.7M, up 15% in Q2 2025Record Asia Pacific (APAC) ADV of 2.2M, up 30% in Q2 2025LONDON and SINGAPORE, July 10, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 9.2 million contracts in Q2 2025, up 18% year over year. Reflecting all trading reported outside the United States, this growth was driven by record quarterly ADV in EMEA and APAC. Quarterly international records were achieved in Interest Rate, Equity Index, Energy, Agricultural and Metals products up 14%, 38%, 23%, 3% and 14% respectively.  "During this period of

      7/10/25 3:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Maloney Patrick W was granted 532 units of Common Stock Class A, increasing direct ownership by 15% to 4,098 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:36:05 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Ford Harold Eugene Jr. was granted 532 units of Common Stock Class A, increasing direct ownership by 34% to 2,091 units (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:35:56 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Director Cook Elizabeth A was granted 532 units of Common Stock Class A (SEC Form 4)

      4 - CME GROUP INC. (0001156375) (Issuer)

      6/26/25 6:35:46 PM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    See more
    • CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

      CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

      5/9/25 10:29:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • CME Clearing Appoints New Chief Risk Officer

      CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

      4/24/25 4:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance
    • Sterling Trading Tech Names Julie Armstrong Chief Commercial Officer

      Chicago , April 23, 2025 (GLOBE NEWSWIRE) -- Sterling Trading Tech (Sterling), a leading global provider of technology in order management, risk and margin, and trading, announced today the appointment of Julie Armstrong as Chief Commercial Officer, a newly created role that underscores the firm's commitment to scaling its business globally. This strategic hire signals Sterling's transition into its next phase of accelerated growth, building on recent momentum across new client segments, product innovation, asset expansion, and geographic reach. Armstrong, a recognized industry expert, brings decades of experience in global fintech strategy and revenue generation. She will lead Sterling'

      4/23/25 2:00:00 AM ET
      $CME
      Investment Bankers/Brokers/Service
      Finance